volume 8, issue 8, P1636-1649 2016
DOI: 10.18632/aging.101019
View full text
|
|
Share

Abstract: This retrospective cohort study investigated whether metformin may reduce gastric cancer risk by using the reimbursement databases of the Taiwan's National Health Insurance. Patients with type 2 diabetes diagnosed during 1999-2005 and newly treated with metformin (n=287971, “ever users of metformin”) or other antidiabetic drugs (n=16217, “never users of metformin”) were followed until December 31, 2011. The effect of metformin (for ever versus never users, and for tertiles of cumulative duration of therapy) wa…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

2
33
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals